Related by context. Frequent words. (Click for all words.) 78 Clinical Trial Results 78 Preclinical Data 76 Chronic Hepatitis C 76 Drug Candidate 76 Phase III Clinical Trial 76 Patient Enrollment 76 Advanced Prostate Cancer 75 Single Dose 74 Phase III Trial 74 Presents Positive 74 Chronic Hepatitis B 74 Completes Enrollment 73 Metastatic Melanoma 73 RNAi Therapeutics 73 FDA Accepts 72 Renal Cell Carcinoma 72 Patients Treated 72 Prostate Cancer Patients 72 Pivotal Phase III 72 FDA Clears 72 Heart Failure Patients 72 Pivotal Study 72 Newly Diagnosed 72 II Clinical Trial 72 Gastric Cancer 71 Malaria Vaccine 71 Autoimmune Disease 71 Cholesterol Drug 71 Combination Therapy 71 Well Tolerated 71 Initiates Phase II 71 Venous Thromboembolism 71 Metastatic Colorectal Cancer 71 Elderly Patients 71 Pivotal Phase 71 Study Demonstrates 71 Monotherapy 70 Pediatric Patients 70 Clinical Outcomes 70 Pulmonary Arterial Hypertension 70 Recombinant Human 70 Hepatitis C Virus 70 Chronic Lymphocytic Leukemia 70 Overactive Bladder 70 Meta Analysis 70 Reduces Risk 70 Smallpox Vaccine 70 Significantly Improves 69 Small Molecule 69 Cervical Cancer Vaccine 69 Patient Outcomes 69 Blood Thinner 69 Early Diagnosis 69 Diabetic Patients 69 Initiate Phase 69 Cethromycin 69 Develop Novel 69 Influenza Vaccine 69 Initiates Phase 69 Cancer Vaccines 69 Drug Resistant 69 Positive Opinion 69 Solid Tumors 69 Atopic Dermatitis 69 Lung Cancer Patients 68 Generic Version 68 Antifungal 68 Benign Prostatic Hyperplasia 68 Breast Cancer Treatment 68 Cancer Immunotherapy 68 Announces Presentation 68 Regimens 68 Significantly Reduces 68 Patients Undergoing 68 Pivotal Trial 68 Golimumab 68 Eculizumab 68 Postmenopausal Women 68 Low Dose 68 Bladder Cancer 68 Autoimmune Diseases 68 Belimumab 68 Boceprevir 67 Cancer Therapies 67 Arch Neurol 67 Cancer Treatments 67 Tolerability 67 Etanercept 67 Announces FDA Clearance 67 Stomach Cancer 67 Immunogenicity 67 Study Indicates 67 Epratuzumab 67 Aliskiren 67 FDA Clearance 67 Dasatinib 67 Panzem R 67 Acute Coronary Syndromes 67 Monoclonal Antibody 66 Increases Risk 66 Carfilzomib